1. Home
  2. CORT vs ESE Comparison

CORT vs ESE Comparison

Compare CORT & ESE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$111.91

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo ESCO Technologies Inc.

ESE

ESCO Technologies Inc.

N/A

Current Price

$295.14

Market Cap

8.1B

ML Signal

N/A

Company Overview

Basic Information
Metric
CORT
ESE
Founded
1998
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.1B
IPO Year
2001
1994

Fundamental Metrics

Financial Performance
Metric
CORT
ESE
Price
$111.91
$295.14
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$96.50
$283.33
AVG Volume (30 Days)
1.3M
174.5K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
0.10%
EPS Growth
N/A
193.15
EPS
0.09
3.71
Revenue
$761,407,000.00
$37,000,000.00
Revenue This Year
$26.08
$21.42
Revenue Next Year
$26.98
$6.99
P/E Ratio
$1,267.14
$123.20
Revenue Growth
12.79
N/A
52 Week Low
$28.66
$182.85
52 Week High
$122.21
$362.15

Technical Indicators

Market Signals
Indicator
CORT
ESE
Relative Strength Index (RSI) 65.59 38.63
Support Level $76.41 $290.64
Resistance Level $122.21 $309.57
Average True Range (ATR) 5.21 11.75
MACD 0.55 -2.06
Stochastic Oscillator 72.40 14.58

Price Performance

Historical Comparison
CORT
ESE

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About ESE ESCO Technologies Inc.

ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace & Defense (A&D), Utility Solutions Group (USG), and RF Test & Measurement (Test). The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.

Share on Social Networks: